Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2023-07-07 | 2023-09-01 | 197884 |
| APO-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2019-07-03 | 2020-01-06 | 88371 |
| APO-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2018-12-05 | 2018-12-19 | 68725 |
| APO-TRAVOPROST Z | 0.004% | SOLUTION | Resolved | 2017-03-11 | 2019-01-03 | 528 |
| APO-TRAVOPROST Z | 0.004% | SOLUTION | Actual shortage | 2019-12-12 | 2019-12-12 | 101100 |
| APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | SOLUTION | Resolved | 2020-02-05 | 2020-03-06 | 105364 |
| APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | SOLUTION | Resolved | 2023-04-27 | 2023-07-13 | 190871 |
| APO-TRAVOPROST-TIMOP PQ | 0.004% 0.5% | SOLUTION | Resolved | 2020-09-30 | 2022-04-01 | 125361 |
| APO-TRAVOPROST-TIMOP PQ | 0.004% 0.5% | SOLUTION | Resolved | 2020-09-30 | 2020-11-02 | 125363 |
| APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | SOLUTION | Resolved | 2023-08-04 | 2023-08-12 | 201162 |
| APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2023-05-19 | 2023-10-06 | 192809 |
| APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2024-01-05 | 2024-03-01 | 215224 |
| APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2022-05-27 | 2022-09-01 | 161456 |
| APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2022-12-16 | 2023-04-21 | 178745 |
| APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2018-03-13 | 2018-12-18 | 42708 |
| APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2021-10-22 | 2021-11-22 | 147826 |
| APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2022-02-04 | 2022-05-06 | 154205 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2023-05-26 | 2023-07-27 | 193221 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2023-08-23 | 2023-10-06 | 202821 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2023-10-27 | 2024-01-05 | 208376 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |